Ran Pang Selected Research

Ran Pang Research Topics

Disease

8	Infections 06/2021 - 07/2008
5	Inflammation (Inflammations) 08/2021 - 07/2008
4	Sepsis (Septicemia) 01/2022 - 01/2021
4	COVID-19 01/2021 - 05/2020
2	Lower Urinary Tract Symptoms 10/2021 - 10/2018
2	Urinary Incontinence 01/2019 - 05/2014
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 06/2016 - 06/2015
2	Hepatoblastoma 01/2011 - 11/2010
1	Acne Vulgaris 02/2022
1	Osteonecrosis (Kienbock's Disease) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 10/2021
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 10/2021
1	Multiple Sclerosis 10/2021
1	Hypoxia (Hypoxemia) 10/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 10/2021
1	Opportunistic Infections (Opportunistic Infection) 06/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2021
1	Urolithiasis 04/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Cicatrix (Scar) 01/2021
1	Hypertrophy 01/2021
1	Neoplasms (Cancer) 06/2020
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2018
1	Stress Urinary Incontinence 01/2017
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 12/2015
1	Fibromyalgia (Fibrositis) 01/2015
1	Back Pain (Backache) 01/2015
1	Vesicular Stomatitis 08/2013
1	Bone Resorption 06/2013
1	Cholestasis 05/2013
1	Malaria 04/2013
1	Kidney Calculi (Kidney Stone) 08/2012
1	Hyperoxaluria (Oxaluria) 08/2012
1	Nephrolithiasis 08/2012
1	Glioblastoma (Glioblastoma Multiforme) 08/2008
1	Chronic Hepatitis B 07/2008
1	Hepatitis B 07/2008

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 06/2020 - 08/2008
3	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2017
3	Antiviral Agents (Antivirals)IBA 08/2013 - 11/2010
2	XuebijingIBA 10/2021 - 08/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 08/2021
2	Type A Botulinum Toxins (Botox)FDA Link 01/2021 - 01/2021
2	GeranyltranstransferaseIBA 06/2013 - 04/2013
2	Diphosphonates (Bisphosphonates)IBA 06/2013 - 04/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 05/2013 - 07/2008
2	corilaginIBA 05/2013 - 07/2008
2	VaccinesIBA 09/2012 - 11/2010
2	Hepatitis B e AntigensIBA 01/2011 - 11/2010
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2011 - 11/2010
2	DNA (Deoxyribonucleic Acid)IBA 11/2010 - 04/2009
1	AntralIBA 02/2022
1	Follicle Stimulating Hormone (Follitropin)FDA Link 02/2022
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 02/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2022
1	Testosterone (Sustanon)FDA Link 02/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	urinastatin (MR 20)IBA 01/2022
1	pimonidazoleIBA 10/2021
1	ChloridesIBA 10/2021
1	Cholinergic Antagonists (Anticholinergics)IBA 10/2021
1	Indicators and Reagents (Reagents)IBA 06/2021
1	N 30IBA 04/2021
1	Citric Acid (Citrate)FDA LinkGeneric 04/2021
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2021
1	CoagulantsIBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	PlasticsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 06/2020
1	Salivary Proteins and PeptidesIBA 06/2020
1	CytokinesIBA 05/2020
1	Solifenacin Succinate FDA Link 01/2019
1	naftopidilIBA 10/2018
1	Tolterodine Tartrate (Detrol)FDA Link 05/2014
1	tat Gene Products (tat Protein)IBA 08/2013
1	Anti-Infective Agents (Microbicides)IBA 06/2013
1	EnzymesIBA 06/2013
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 05/2013
1	1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA 05/2013
1	Farnesyltranstransferase (Farnesyltransferase)IBA 04/2013
1	Pharmaceutical PreparationsIBA 10/2012
1	EpitopesIBA 09/2012
1	Calcium OxalateIBA 08/2012
1	OxalatesIBA 08/2012
1	LuteinIBA 11/2010
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 06/2010
1	NF-kappa B (NF-kB)IBA 09/2008
1	naphthaIBA 09/2008
1	NestinIBA 08/2008
1	TubulinIBA 08/2008

Therapy/Procedure

4	Therapeutics 10/2021 - 05/2014
4	Electroacupuncture 01/2019 - 05/2014
3	Punctures 01/2022 - 01/2021
3	Ligation 01/2022 - 01/2021
1	Injections 08/2021
1	Rejuvenation 11/2020
1	Complementary Therapies (Alternative Medicine) 12/2015
1	Acupuncture Points (Acupuncture Point) 06/2015
1	Massage (Zone Therapy) 01/2015
1	Bariatric Surgery 08/2012